Combination of bevacizumab and chemotherapy for platinum-resistant recurrent ovarian cancer: some observations about the AURELIA trial
- PMID: 25185105
- DOI: 10.1200/JCO.2014.57.6231
Combination of bevacizumab and chemotherapy for platinum-resistant recurrent ovarian cancer: some observations about the AURELIA trial
Comment in
-
Reply to F. Tomao et al.J Clin Oncol. 2014 Nov 1;32(31):3580. doi: 10.1200/JCO.2014.57.7379. Epub 2014 Sep 2. J Clin Oncol. 2014. PMID: 25185088 No abstract available.
Comment on
-
Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial.J Clin Oncol. 2014 May 1;32(13):1302-8. doi: 10.1200/JCO.2013.51.4489. Epub 2014 Mar 17. J Clin Oncol. 2014. PMID: 24637997 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical